MoneyWorks4Me

Jubilant Life Sciences’ consolidated Q1 net profit rose 52.92%

09 Aug 2011 Evaluate

Jubilant Life Sciences has reported unaudited results for the second quarter ended June 30, 2011.

The company’s net profit declined by 20.50% to Rs 53.89 crore for the first quarter ended June 30, 2011, against Rs 67.79 crore in the same period previous fiscal. Total income rose to Rs 618.75 crore for the quarter ended June 30, 2011, up by 18.84% compared with Rs 520.64 crore in the same period previous financial year.

The company’s consolidated net profit rose 52.92% to Rs 77.12 crore for the first quarter ended June 30, 2011, against Rs 50.43 crore in the same period previous fiscal. Total income rose to Rs 948.48 crore for the quarter ended June 30, 2011 up by 15.86% compared with Rs 818.61 crore in the same period previous financial year.

Peers
Company Name CMP
Sun Pharma. Inds. 1873.20
Dr. Reddys Labs. 1208.00
Cipla 1384.55
Lupin 2111.00
Zydus Lifesciences 1158.20
View more..